Viewing Study NCT01649869


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-31 @ 9:28 AM
Study NCT ID: NCT01649869
Status: COMPLETED
Last Update Posted: 2024-10-16
First Post: 2012-07-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-02-24
Start Date Type: ACTUAL
Primary Completion Date: 2019-12-24
Primary Completion Date Type: ACTUAL
Completion Date: 2019-12-24
Completion Date Type: ACTUAL
First Submit Date: 2012-07-20
First Submit QC Date: None
Study First Post Date: 2012-07-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-12-23
Results First Submit QC Date: None
Results First Post Date: 2021-06-02
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-11
Last Update Post Date: 2024-10-16
Last Update Post Date Type: ACTUAL